How Trump's Policies Moved Stocks - Dec. 23

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Trump and his administration with this weekly recap compiled by The Fly:

1. SOCIAL MEDIA ‘SO BIASED’: U.S. President Donald Trump tweeted on Tuesday that, "Facebook (FB), Twitter (TWTR) and Google (GOOG, GOOGL) are so biased toward the Dems it is ridiculous! Twitter, in fact, has made it much more difficult for people to join @realDonaldTrump. They have removed many names & greatly slowed the level and speed of increase. They have acknowledged-done NOTHING!"

2. TAX BREAK FOR ALCOHOL COMPANIES BLOCKED: The White House finalized a regulation limiting the ability of U.S. wineries and global alcohol companies to cut import taxes, the Wall Street Journal reported on Monday. The government believes the new rules stop wine and liquor companies from double-dipping on tax breaks, and argues that the companies are getting or seeking a tax advantage for imports over domestic production, the report noted. Publicly traded alcohol companies include Diageo (DEO), Constellation Brands (STZ) and Brown-Forman (BF-A, BF-B).

3. DRUG INDUSTRY: After Reuters reported that nearly 30 drugmakers are planning to raise the prices of their medicines in the U.S. starting in January, including Novartis (NVS), Bayer (BAYRY), GlaxoSmithKline (GSK), Amgen (AMGN), AstraZeneca (AZN), Biogen (BIIB) and Allergan (AGN), Wells Fargo analyst David Maris told investors in a research note earlier this week that he has repeatedly highlighted how the practice of drug price increases is a risk for the industry, and believes the latest actions by these manufacturers will be "front and center" for the Trump administration heading towards an election year. Further, the analyst pointed out that he expects to see increased political and legislative pressure on drug prices as Democrats take over the House in January, and continues to believe that the drug industry is facing a "brave new world" with greater scrutiny of drug prices, lower price increases versus historical levels, and as a result potentially lower profit margins.

1 2
View single page >> |

Disclaimer: TheFly's news is intended for informational purposes only and does not claim to be actionable for investment decisions. Read more at  more

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.